Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Oxidative stress in malignant and non-malignant phase hypertension

Abstract

Malignant hypertension (MHT) is a rare and severe form of hypertension characterised by arteriolar necrosis and severe vascular damage, leading to stroke, myocardial infarction and death. We hypothesised that in addition to endothelial damage, MHT may be associated with increased oxidative stress. Lipid hydroperoxides (LHP, an index of oxidative damage) and plasma von Willebrand factor (vWf, an index of endothelial damage/dysfunction) were measured in 16 patients with MHT and compared with 16 non-malignant essential hypertensives and 32 normotensive controls. vWf was greater in MHT (mean 117 iU/dL) than in non-malignant hypertensives (97 iU/dL) or normotensive controls (100 iU/dL) (ANOVA P = 0.017). However, although LHP were greater in MHT (mean 10.6 μmol/L) than in normotensives (4.5 μmol/L, P < 0.001), the levels in MHT were similar to those in non-malignant hypertension (12.3 μmol/L). In conclusion endothelial damage (raised vWf) was more evident in MHT compared with both normotensive controls and with non-malignant hypertension, whilst oxidative stress (raised LHP) was increased to a similar extent in both hypertension groups when compared with normotensive controls. These observations raise the possibility abnormal oxidative stress is probably not the mechanism responsible for the endothelial damage seen in malignant phase hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Keith NM, Wagener HP, Barker NW . Some different types of essential hypertension, their course and prognosis Am J Med Sci 1939; 196: 332–343

    Article  Google Scholar 

  2. Leishman AWD . Hypertension-treated and untreated: a study of 400 cases Br Med J 1959; 1: 1361–1363

    Article  CAS  Google Scholar 

  3. Lip GYH, Beevers M, Beevers DG . Complications and survival of 315patients with malignant-phase hypertension J Hypertens 1995; 13: 915–924

    Article  CAS  Google Scholar 

  4. Lip GYH, Beevers M, Beevers DG . The failure of malignant hypertension to decline: a survey of 24 years’ experience J Hypertens 1994; 12: 1297–1305

    Article  CAS  Google Scholar 

  5. Ahmed MEK, Walker JM, Beevers DG, Beevers M . Lack of difference between malignant and accelerated hypertension Br Med J 1986; 292: 235–237

    Article  CAS  Google Scholar 

  6. Nourooz-Zadeh J, Tajaddinni-Sarmadi F, Wolff SP . Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphospine Ann Biochem 1994; 220: 403–409

    Article  CAS  Google Scholar 

  7. Blann AD, Lip GYH . The endothelium in atherothrombotic disease: Assessment of function, mechanisms and clinical implications Blood Coagulation Fibrinolysis 1998; 9: 297–306

    Article  CAS  Google Scholar 

  8. Lee AJ . The role of rheology and haemostatic factors in hypertension J Hum Hypertens 1997; 11: 767–776

    Article  CAS  Google Scholar 

  9. Lip GYH, Blann AD, Beevers DG . Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension J Hypertens 1999; 17: 1203–1207

    Article  CAS  Google Scholar 

  10. Lip GYH, Blann AD, Jones AF, Lip PL, Beevers DG . Relation of endothelium, thrombogenesis and haemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy Am J Cardiol 1997; 80: 1566–1571

    Article  CAS  Google Scholar 

  11. Nuttall SL, Cox G, Kendall MJ, Martin U, Temple RM . Vitamin supplementation reduces oxidative stress inpatients with conservatively managed chronic renal failure J Am Soc Nephrol 1999; 10: 83A

    Google Scholar 

Download references

Acknowledgements

We acknowledge the support of the City Hospital NHS Trust Research and Development programme for the Haemostasis Thrombosis and Vascular Biology Unit.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Y H Lip.

Additional information

This paper was submitted to, and dealt with by, the USA Editorial Office of the Journal of Human Hypertension.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lip, G., Edmunds, E., Nuttall, S. et al. Oxidative stress in malignant and non-malignant phase hypertension. J Hum Hypertens 16, 333–336 (2002). https://doi.org/10.1038/sj.jhh.1001386

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001386

Keywords

This article is cited by

Search

Quick links